Ian Walters

Dr. Ian Walters is the Chairman and Chief Executive Officer of Portage Biotech Inc., a clinical-stage immuno-oncology company based in Westport, Connecticut.12 He was appointed as Chairman of the Board of Directors in August 2022, taking on this additional role alongside his existing position as CEO.14

Professional Background

Dr. Walters has an extensive background in the biotech and pharmaceutical industry:

• He holds an MD and an MBA, indicating a strong combination of medical and business expertise.3
• He has been instrumental in Portage Biotech's growth and progress, leading the company's efforts to advance its pipeline of cancer treatments.1
• Under his leadership, Portage Biotech focuses on developing first-in-class therapies targeting checkpoint resistance pathways in cancer treatment.2

Achievements and Expertise

Dr. Walters is known for:

• Contributing to five oncology drug approvals throughout his career.2
• Being part of a team that has created high-value exits in the biotech industry.2
• His expertise in identifying promising clinical therapies and efficiently packaging them for commercialization or acquisition.2

Notable Projects

One of Dr. Walters' most significant accomplishments includes:

• Early investment, formation, and growth of Biohaven Pharmaceuticals, which led to the second-largest IPO in 2017 and was later acquired by Pfizer for approximately $12 billion in 2022.2

Dr. Walters' LinkedIn profile can be found under the username ian-walters-b59825, where he is listed as being based in Westport, Connecticut, with over 500 connections.5